Novavax, Inc.

NASDAQ: NVAX
$94.36
-$1.94 (-2.0%)
Closing price July 10, 2020
Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney and Wells Fargo.
Novavax and Regeneron Pharmaceuticals each made solid progress on Tuesday after each company received a sizable capital injection from the U.S. government’s Operation Warp Speed program.
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Friday's top analyst upgrades and downgrades included Darden Restaurants, DuPont, EOG Resources, Lululemon Athletica, Micron Technology, Occidental Petroleum, Slack, Spotify, Ulta Beauty and Walt...
Novavax shares jumped to start off the week after an update from its COVID-19 vaccine trial. This news adds to investor optimism and is helping to lift the broad markets in general.
Monday's top analyst upgrades and downgrades included Apple, Best Buy, Cinemark, Co-Diagnostics, DraftKings, Energizer, Novavax, Nvidia, Palo Alto Networks and Petrobras.
Novavax shares jumped on Tuesday after the company announced that it would be receiving a sizable investment to further produce its COVID-19 vaccine.
Tuesday's top analyst upgrades and downgrades included Apple, CenterPoint Energy, Chevron, Datadog, Home Depot, Novavax and Under Armour.
Friday's top analyst upgrades and downgrades included Arch Coal, AT&T, Delphi Technologies, Domino's Pizza, Dunkin Brands, Expedia, Illumina, Kinder Morgan, Oceaneering International, Splunk and...
Friday's top analyst upgrades and downgrades included American Airlines, Chipotle Mexican Grill, Ericsson, Microsoft, Mylan, Novavax, Pfizer, Procter & Gamble, Qualcomm, Square and Starbucks.
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting...
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Tuesday's top analyst upgrades, downgrades and initiations included Amazon.com, Apple, Bank of America, Cinemark, Coupa Software, Ecolab, Novavax, Pepsico, Procter & Gamble, Square and Walmart.